Although the mechanism of pathogenesis of polyQ diseases is still not fully characterized and understood, evidence suggests that post-translational modifications of the polyglutamine proteins are involved in their neurotoxicity and can significantly modulate it. Posttranslational modifications take place on amino acids out of the polyQ tract and frequently affect protein-protein interactions or function.